XML 27 R18.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Earnings per Share (EPS) | 9 Months Ended
--- | ---
Sep. 30, 2022
Earnings Per Share [Abstract] |
Earnings per Share (EPS) | Earnings per Share (EPS) The following table reconciles the net income and the weighted average common shares outstanding used in the computations of basic and diluted earnings per common share:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(In thousands, except per share amounts) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Net income |  | $ | 178,051 |  |  | $ | 205,353 |  |  | $ | 683,987 |  |  | $ | 500,796 |
Basic weighted average shares outstanding |  | 106,870 |  |  | 111,001 |  |  | 107,314 |  |  | 111,708 |
Dilutive effect of nonvested shares |  | 467 |  |  | 386 |  |  | 418 |  |  | 362 |
Diluted weighted average shares outstanding |  | 107,337 |  |  | 111,387 |  |  | 107,732 |  |  | 112,070 |
Basic earnings per share |  | $ | 1.67 |  |  | $ | 1.85 |  |  | $ | 6.37 |  |  | $ | 4.48 |
Diluted earnings per share |  | $ | 1.66 |  |  | $ | 1.84 |  |  | $ | 6.35 |  |  | $ | 4.47 |
There were 10,417 and 181,476 antidilutive shares for the three months ended September 30, 2022 and 2021, respectively, and 90,413 and 230,595 antidilutive shares for the nine months ended September 30, 2022 and 2021, respectively. The nonvested performance-based share awards are considered contingently issuable for purposes of the EPS calculation. Based on the compounded annual book value per share growth and relative total shareholder return as of September 30, 2022, the 2022 performance-based share awards would be issuable at 146% of target under the terms of the arrangements if September 30, 2022 was the end of the contingency period, which is 73% of the shares issued and the 2021 performance-based share awards would be issuable at 100% of target under the terms of the arrangements if September 30, 2022 was the end of the contingency period, which is 50% of the shares issued. Based on the compounded annual book value per share growth and relative total shareholder return as of September 30, 2021, the 2021 performance-based share awards would be issuable at 100% of target under the terms of the arrangements if September 30, 2021 was the end of the contingency period, which is 50% of the shares issued.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration